Tevogen Bio® Expresses Gratitude for 2023 Nobel Peace Prize Nomination of the Company and its Foundi
Tevogen Bio® and Founding CEO are nominated for the 2023 Nobel Peace Prize by Curtis Patton, PhD, Professor Emeritus, Yale School of Public Health, Yale UniversityWARREN, N.J.--(BUSINESS WIRE)--#celltherapies--Tevogen Bio®, is a late-stage clinical biotechnology company specializing in the development of cellular im...